Microneedling has long occupied an ambiguous position in aesthetic medicine – simultaneously ubiquitous and underestimated. Widely adopted for its ability to refine texture, soften scarring and restore radiance, it is often reduced to a simple mechanical act. Yet this perception obscures a far more sophisticated reality.
When examined through a clinical and molecular lens, microneedling emerges not as a cosmetic shortcut, but as a precise biological stimulus, capable of coordinating meaningful dermal regeneration when performed with restraint and intent.
At its foundation, microneedling involves the creation of controlled vertical microchannels through the epidermis and into the superficial dermis. These micro-injuries are calculated, graduated and – most importantly – non-thermal. Their purpose is not damage, but communication: signalling the skin to initiate its own reparative processes.
“At a biological level, microneedling works by creating controlled micro-injuries in the epidermis and superficial dermis,” explains Dr. Eugenia de Luna, Medical Director of Education & Scientific Development at pHformula, a dermatological brand internationally recognised for its science-led approach to controlled skin resurfacing. “This triggers the skin’s natural wound-healing cascade, progressing into fibroblast activation, angiogenesis and the synthesis of new extracellular matrix components – most notably collagen types I and III – followed by gradual remodelling over time.”
Crucially, she emphasises, microneedling is “a process of biological stimulation rather than destructive injury” – a distinction that underpins both the safety and long-term efficacy of the procedure.
From a molecular perspective, this regenerative response is driven by a tightly regulated release of growth factors and cytokines. According to Dr. Edris Farahbod at the Longevity Hub by Clinique La Prairie – a Dubai-based medical-wellness and longevity clinic renowned for its preventative and regenerative medicine programmes – platelet activation following microneedling releases mediators such as PDGF, TGF-beta, VEGF, EGF and FGF.
“These signals stimulate fibroblast migration and proliferation, support collagen and elastin synthesis, and reorganise the extracellular matrix,” says Dr. Farahbod. Temporary activation of matrix metalloproteinases allows damaged collagen to be broken down before newly organised fibres are deposited through controlled signalling pathways. The result is regeneration that is progressive, organised, and biologically coherent – rather than chaotic or inflammatory.
Skin Colour, Inflammation and Clinical Precision
Across all Fitzpatrick skin phototypes, a system that defines skin type by its reaction to ultraviolet radiation, the fibroblast-driven collagen response to microneedling remains fundamentally consistent. What differs is not the skin’s capacity to regenerate, but its inflammatory and pigmentary response.
“Medium to darker phototypes may exhibit a more pronounced or prolonged post-inflammatory reaction, increasing the risk of hyperpigmentation,” explains Dr. de Luna. “For these patients, technique, parameter selection and inflammation control are far more critical than the indication itself.”
Dr. Farahbod echoes this, noting that Fitzpatrick III to VI skin is prone to post-inflammatory hyperpigmentation primarily due to melanocyte sensitivity, not impaired collagen synthesis. Clinically, this means using conservative depths, fewer passes and minimal overlap, alongside pre-treatment melanocyte stabilisation and strict post-treatment photoprotection.
Scar Morphology and Therapeutic Outcomes
Not all scars respond equally. Rolling acne scars demonstrate the most consistent improvement due to collagen induction and the release of fibrotic tethering. Shallow boxcar scars respond moderately well, while deep boxcar and icepick scars typically require adjunctive treatments such as subcision or chemical reconstruction.
“I am cautious in patients with a personal or family history of hypertrophic or keloid scarring,” Dr. de Luna tells MOJEH. “Excessive dermal injury may worsen fibrosis rather than improve it.” Dr. Farahbod adds that microneedling should be avoided in hypertrophic or keloid-prone scars, reinforcing the importance of individualised assessment.
Hormones, PCOS and Hair Growth
Systemic hormonal conditions, particularly PCOS [polycystic ovary syndrome], can finely influence cutaneous healing. PCOS is associated with androgen excess, insulin resistance and chronic low-grade inflammation, which may present clinically as delayed recovery, prolonged erythema or acne exacerbation.
“PCOS creates a systemic environment that can influence cutaneous healing,” explains Dr. de Luna. “I ensure inflammatory acne is well controlled before performing deeper microneedling procedures.”
Dr. Farahbod concurs: in these patients, longer intervals between treatments and enhanced anti-inflammatory post-procedure care are advised.
One of the most persistent misconceptions is that microneedling stimulates unwanted facial hair growth. “This is a common misconception,” says Dr. de Luna. “Microneedling does not alter systemic hormonal signalling and does not convert vellus hair into terminal hair.”
Dr. Farahbod adds that scalp improvements are linked to vascular perfusion and enhanced topical drug penetration, not follicular activation. On the face, perceived hair growth is usually due to hormonal factors or improved visibility of fine hairs.
Professional Treatment vs At-Home Devices
There are plenty of devices on the market that promise treatment-worthy results, however the difference between professional microneedling and at-home dermarollers is stark. “In clinical settings, treatments are performed using sterile, single-use cartridges, controlled depths and structured aftercare,” says Dr. de Luna. “Home use often involves poor hygiene, excessive pressure, and inappropriate application of active products, increasing risks of infection, pigmentary changes, or scarring.”
Dr. Farahbod adds that improper at-home techniques carry unpredictable penetration and uncontrolled trauma, particularly risky in medium to deeper skin tones.
Treatment Frequency and Long-Term Outcomes
Optimal treatment intervals are generally four to six weeks for rejuvenation and six to eight weeks for acne scarring, allowing collagen synthesis and remodelling.
“Properly spaced and conservative treatments result in cumulative dermal thickening and improved collagen organisation,” notes Dr. Farahbod. “Problems arise only when treatments are too frequent or aggressive.” Dr. de Luna concurs: patience and precision are essential for long-term structural integrity.
Barrier repair, inflammation control and photoprotection form the non-negotiable triad of post-microneedling care. Immediate support with ceramides, hyaluronic acid and panthenol, alongside broad-spectrum sunscreen covering visible light, is essential.
“Excessive inflammation compromises outcomes, particularly in darker phototypes,” warns Dr. de Luna. Dr. Farahbod echoes this, noting patient non-compliance is the most common cause of adverse effects.
The Shift Towards Intelligent Regeneration
Recent technological developments prioritise precision and reproducibility. Automated depth control, insulated needle systems and radiofrequency-assisted microneedling have expanded treatment possibilities while improving safety.
Beyond devices, both experts highlight a conceptual shift: at pHformula, microneedling is part of controlled dermatological resurfacing, integrating solution-driven and spicule-based technologies such as MESORESURFACING™ and MESO X Boost, alongside regenerative, exosome-inspired approaches.
“Modern microneedling isn’t about force – it’s about supporting biological signalling,” explains Dr. de Luna.
Dr. Farahbod adds that at Clinique La Prairie, microneedling is embedded in a broader longevity framework, prioritising long-term tissue health over short-term intensity.
Microneedling’s true value lies in intelligent delivery, not aggression. It rewards precision, patience and respect for individual variation. In its modern form, microneedling is no longer a trend-driven aesthetic intervention. It represents a disciplined engagement with skin biology, a procedure that is as much about understanding the patient as it is about the device.
Featured image photographed by Arya Shirazi for MOJEH 79
